Home/Filings/4/0001062993-20-005748

4//SEC Filing

ARCH Venture Partners IX, LLC 4

Accession 0001062993-20-005748

CIK 0001771917other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:14 PM ET

Size

20.8 KB

Accession

0001062993-20-005748

Insider Transaction Report

Form 4

Period: 2020-11-12

Karuna Therapeutics, Inc.KRTX

ARCH Venture Partners IX, LLC

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total
Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+306→ 306 total

ARCH Venture Fund IX, L.P.

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total
Other
Common Stock
2020-11-12+306→ 306 total

BYBEE CLINTON

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+306→ 306 total
Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total

ARCH Venture Partners IX Overage, L.P.

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total
Other
Common Stock
2020-11-12+306→ 306 total
Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)

ARCH Venture Fund IX Overage, L.P.

10% Owner

Transactions

Other
Common Stock
2020-11-12+958→ 958 total
Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+306→ 306 total

CRANDELL KEITH

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total
Other
Common Stock
2020-11-12+306→ 306 total

ARCH Venture Partners IX, L.P.

10% Owner

Transactions

Other
Common Stock
2020-11-12−75,000→ 1,606,437 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+306→ 306 total
Other
Common Stock
2020-11-12−75,000→ 1,606,435 total(indirect: See Footnote)
Other
Common Stock
2020-11-12+958→ 958 total

Footnotes (6)

[F1]Distribution of Common Stock held by a limited partnership to its partners for no consideration.
[F2]These shares are directly held by ARCH Venture Fund IX, L.P. ("ARCH IX"). ARCH Venture Partners IX, L.P. ("GPLP"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the "ARCH Managing Directors"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
[F3]These shares are directly held by ARCH Venture Fund IX Overage, L.P. ("ARCH Overage"). ARCH Venture Partners IX Overage, L.P. ("Overage GPLP"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any.
[F4]Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
[F5]Shares held directly by Crandell.
[F6]Shares held directly by Bybee.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Karuna Therapeutics, Inc.

CIK 0001771917

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001723174

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 6:14 PM ET
Size: 20.8 KB

View on SEC.gov